Re: Rituximab for refractory head and neck Wegener's granulomatosis.
Ibrahim
A S
AS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006257:Head; D006801:Humans; D009296:Nasal Cavity / Q000382:microbiology / Q000473:pathology; D009333:Neck; D000069283:Rituximab; D013203:Staphylococcal Infections / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab